Loading...
Header Logo
Keywords
Last Name
Institution

BOGDAN A CZERNIAK

TitleProfessor
InstitutionMD Anderson
DepartmentPathology
Address1515 Holcombe Blvd
Houston TX 77030-4009
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Guo CC, Czerniak B. Bladder Cancer in the Genomic Era. Arch Pathol Lab Med. 2019 Jan 23. PMID: 30672335.
      View in: PubMed
    2. Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, Czerniak BA, Reuter VE, Su X, de Sa Carvalho B, Chagas VS, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, Mills GB, McConkey DJ, Weinstein JN, Kwiatkowski DJ, Lerner SP. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell. 2018 Aug 09; 174(4):1033. PMID: 30096301.
      View in: PubMed
    3. van der Heijden AG, Mengual L, Ingelmo-Torres M, Lozano JJ, van Rijt-van de Westerlo CCM, Baixauli M, Geavlete B, Moldoveanud C, Ene C, Dinney CP, Czerniak B, Schalken JA, Kiemeney LALM, Ribal MJ, Witjes JA, Alcaraz A. Urine cell-based DNA methylation classifier for monitoring bladder cancer. Clin Epigenetics. 2018; 10:71. PMID: 29854012.
      View in: PubMed
    4. Wang G, Xiao L, Zhang M, Kamat AM, Siefker-Radtke A, Dinney CP, Czerniak B, Guo CC. Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases. Hum Pathol. 2018 Sep; 79:57-65. PMID: 29763719.
      View in: PubMed
    5. Zhang S, Wang Y, Bondaruk J, Majewski T, Yao H, Lee S, Lee JG, Cogdell D, Lotan Y, Dinney C, Wei P, Baggerly K, Czerniak B. Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test. Eur Urol Focus. 2018 Feb 07. PMID: 29428551.
      View in: PubMed
    6. Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, Czerniak BA, Reuter VE, Su X, de Sa Carvalho B, Chagas VS, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, Mills GB, McConkey DJ, Weinstein JN, Kwiatkowski DJ, Lerner SP. Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell. 2017 Oct 19; 171(3):540-556.e25. PMID: 28988769.
      View in: PubMed
    7. Zhang M, Adeniran AJ, Vikram R, Tamboli P, Pettaway C, Bondaruk J, Liu J, Baggerly K, Czerniak B. Carcinoma of the urethra. Hum Pathol. 2018 02; 72:35-44. PMID: 28827100.
      View in: PubMed
    8. Wang G, Huang H, Kamat AM, Siefker-Radtke A, Dinney CP, Troncoso P, Czerniak B, Guo CC. High-grade neuroendocrine carcinoma of the urachus-report of 3 cases. Hum Pathol. 2017 09; 67:126-133. PMID: 28823575.
      View in: PubMed
    9. Wang Z, Kim TB, Peng B, Karam J, Creighton C, Joon A, Kawakami F, Trevisan P, Jonasch E, Chow CW, Canales JR, Tamboli P, Tannir N, Wood C, Monzon F, Baggerly K, Varella-Garcia M, Czerniak B, Wistuba I, Mills G, Shaw K, Chen K, Sircar K. Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional Landscape. Clin Cancer Res. 2017 Nov 01; 23(21):6686-6696. PMID: 28710314.
      View in: PubMed
    10. Metcalfe MJ, Ferguson JE, Li R, Xiao L, Guo CC, Czerniak BA, Siefker-Radtke A, Pretzsch SM, Navai N, McConkey DJ, Kamat AM, Campbell M, Dinney C. Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle Invasion. Eur Urol Focus. 2017 12; 3(6):577-583. PMID: 28753816.
      View in: PubMed
    11. Moss TJ, Qi Y, Xi L, Peng B, Kim TB, Ezzedine NE, Mosqueda ME, Guo CC, Czerniak BA, Ittmann M, Wheeler DA, Lerner SP, Matin SF. Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma. Eur Urol. 2017 10; 72(4):641-649. PMID: 28601352.
      View in: PubMed
    12. Roth B, Jayaratna I, Sundi D, Cheng T, Melquist J, Choi W, Porten S, Nitti G, Navai N, Wszolek M, Guo C, Czerniak B, McConkey D, Dinney C. Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis. Oncotarget. 2017 May 23; 8(21):34205-34222. PMID: 27494900.
      View in: PubMed
    13. Fox MD, Xiao L, Zhang M, Kamat AM, Siefker-Radtke A, Zhang L, Dinney CP, Czerniak B, Guo CC. Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases. Am J Clin Pathol. 2017 May 01; 147(5):500-506. PMID: 28371875.
      View in: PubMed
    14. Murugan P, Rao P, Tamboli P, Czerniak B, Guo CC. Primary Ewing Sarcoma / Primitive Neuroectodermal Tumor of the Kidney: A Clinicopathologic Study of 23 Cases. Pathol Oncol Res. 2018 Jan; 24(1):153-159. PMID: 28429277.
      View in: PubMed
    15. Mobley A, Zhang S, Bondaruk J, Wang Y, Majewski T, Caraway NP, Huang L, Shoshan E, Velazquez-Torres G, Nitti G, Lee S, Lee JG, Fuentes-Mattei E, Willis D, Zhang L, Guo CC, Yao H, Baggerly K, Lotan Y, Lerner SP, Dinney C, McConkey D, Bar-Eli M, Czerniak B. Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior. Sci Rep. 2017 01 19; 7:40714. PMID: 28102366.
      View in: PubMed
    16. Ochoa AE, Choi W, Su X, Siefker-Radtke A, Czerniak B, Dinney C, McConkey DJ. Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer. Oncotarget. 2016 Dec 06; 7(49):80164-80174. PMID: 27845906.
      View in: PubMed
    17. Fernández MI, Williams SB, Willis DL, Slack RS, Dickstein RJ, Parikh S, Chiong E, Siefker-Radtke AO, Guo CC, Czerniak BA, McConkey DJ, Shah JB, Pisters LL, Grossman HB, Dinney CP, Kamat AM. Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer. BJU Int. 2017 05; 119(5):684-691. PMID: 27753185.
      View in: PubMed
    18. Yang J, Platt LT, Maity B, Ahlers KE, Luo Z, Lin Z, Chakravarti B, Ibeawuchi SR, Askeland RW, Bondaruk J, Czerniak BA, Fisher RA. RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation. Oncotarget. 2016 Oct 25; 7(43):69159-69172. PMID: 27713144.
      View in: PubMed
    19. Tetzlaff MT, Singh RR, Seviour EG, Curry JL, Hudgens CW, Bell D, Wimmer DA, Ning J, Czerniak BA, Zhang L, Davies MA, Prieto VG, Broaddus RR, Ram P, Luthra R, Esmaeli B. Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma. J Pathol. 2016 09; 240(1):84-95. PMID: 27287813.
      View in: PubMed
    20. Dadhania V, Zhang M, Zhang L, Bondaruk J, Majewski T, Siefker-Radtke A, Guo CC, Dinney C, Cogdell DE, Zhang S, Lee S, Lee JG, Weinstein JN, Baggerly K, McConkey D, Czerniak B. Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use. EBioMedicine. 2016 Oct; 12:105-117. PMID: 27612592.
      View in: PubMed
    21. Zhang L, Baladandayuthapani V, Zhu H, Baggerly KA, Majewski T, Czerniak BA, Morris JS. Functional CAR models for large spatially correlated functional datasets. J Am Stat Assoc. 2016; 111(514):772-786. PMID: 28018013.
      View in: PubMed
    22. Oshiro H, Czerniak BA, Sakamaki K, Tsuta K, Bondaruk J, Keyhani A, Dinney CP, Nagai T, Kamat AM. Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer: A cross-sectional study. Medicine (Baltimore). 2016 Aug; 95(31):e4500. PMID: 27495099; PMCID: PMC4979853.
    23. Olivieri M, Ferro M, Terreri S, Durso M, Romanelli A, Avitabile C, De Cobelli O, Messere A, Bruzzese D, Vannini I, Marinelli L, Novellino E, Zhang W, Incoronato M, Ilardi G, Staibano S, Marra L, Franco R, Perdonà S, Terracciano D, Czerniak B, Liguori GL, Colonna V, Fabbri M, Febbraio F, Calin GA, Cimmino A. Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis. Oncotarget. 2016 Apr 12; 7(15):20636-54. PMID: 26943042; PMCID: PMC4991481.
    24. Guo CC, Dadhania V, Zhang L, Majewski T, Bondaruk J, Sykulski M, Wronowska W, Gambin A, Wang Y, Zhang S, Fuentes-Mattei E, Kamat AM, Dinney C, Siefker-Radtke A, Choi W, Baggerly KA, McConkey D, Weinstein JN, Czerniak B. Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer. Eur Urol. 2016 10; 70(4):611-620. PMID: 26988609.
      View in: PubMed
    25. Czerniak B, Dinney C, McConkey D. Origins of Bladder Cancer. Annu Rev Pathol. 2016 05 23; 11:149-74. PMID: 26907529.
      View in: PubMed
    26. Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, Wheeler DA, Murray BA, Schmidt L, Vocke CD, Peto M, Al Mamun AA, Shinbrot E, Sethi A, Brooks S, Rathmell WK, Brooks AN, Hoadley KA, Robertson AG, Brooks D, Bowlby R, Sadeghi S, Shen H, Weisenberger DJ, Bootwalla M, Baylin SB, Laird PW, Cherniack AD, Saksena G, Haake S, Li J, Liang H, Lu Y, Mills GB, Akbani R, Leiserson MD, Raphael BJ, Anur P, Bottaro D, Albiges L, Barnabas N, Choueiri TK, Czerniak B, Godwin AK, Hakimi AA, Ho TH, Hsieh J, Ittmann M, Kim WY, Krishnan B, Merino MJ, Mills Shaw KR, Reuter VE, Reznik E, Shelley CS, Shuch B, Signoretti S, Srinivasan R, Tamboli P, Thomas G, Tickoo S, Burnett K, Crain D, Gardner J, Lau K, Mallery D, Morris S, Paulauskis JD, Penny RJ, Shelton C, Shelton WT, Sherman M, Thompson E, Yena P, Avedon MT, Bowen J, Gastier-Foster JM, Gerken M, Leraas KM, Lichtenberg TM, Ramirez NC, Santos T, Wise L, Zmuda E, Demchok JA, Felau I, Hutter CM, Sheth M, Sofia HJ, Tarnuzzer R, Wang Z, Yang L, Zenklusen JC, Zhang J, Ayala B, Baboud J, Chudamani S, Liu J, Lolla L, Naresh R, Pihl T, Sun Q, Wan Y, Wu Y, Ally A, Balasundaram M, Balu S, Beroukhim R, Bodenheimer T, Buhay C, Butterfield YS, Carlsen R, Carter SL, Chao H, Chuah E, Clarke A, Covington KR, Dahdouli M, Dewal N, Dhalla N, Doddapaneni HV, Drummond JA, Gabriel SB, Gibbs RA, Guin R, Hale W, Hawes A, Hayes DN, Holt RA, Hoyle AP, Jefferys SR, Jones SJ, Jones CD, Kalra D, Kovar C, Lewis L, Li J, Ma Y, Marra MA, Mayo M, Meng S, Meyerson M, Mieczkowski PA, Moore RA, Morton D, Mose LE, Mungall AJ, Muzny D, Parker JS, Perou CM, Roach J, Schein JE, Schumacher SE, Shi Y, Simons JV, Sipahimalani P, Skelly T, Soloway MG, Sougnez C, Tam A, Tan D, Thiessen N, Veluvolu U, Wang M, Wilkerson MD, Wong T, Wu J, Xi L, Zhou J, Bedford J, Chen F, Fu Y, Gerstein M, Haussler D, Kasaian K, Lai P, Ling S, Radenbaugh A, Van Den Berg D, Weinstein JN, Zhu J, Albert M, Alexopoulou I, Andersen JJ, Auman JT, Bartlett J, Bastacky S, Bergsten J, Blute ML, Boice L, Bollag RJ, Boyd J, Castle E, Chen YB, Cheville JC, Curley E, Davies B, DeVolk A, Dhir R, Dike L, Eckman J, Engel J, Harr J, Hrebinko R, Huang M, Huelsenbeck-Dill L, Iacocca M, Jacobs B, Lobis M, Maranchie JK, McMeekin S, Myers J, Nelson J, Parfitt J, Parwani A, Petrelli N, Rabeno B, Roy S, Salner AL, Slaton J, Stanton M, Thompson RH, Thorne L, Tucker K, Weinberger PM, Winemiller C, Zach LA, Zuna R. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med. 2016 Jan 14; 374(2):135-45. PMID: 26536169.
      View in: PubMed
    27. McConkey DJ, Choi W, Shen Y, Lee IL, Porten S, Matin SF, Kamat AM, Corn P, Millikan RE, Dinney C, Czerniak B, Siefker-Radtke AO. A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer. Eur Urol. 2016 05; 69(5):855-62. PMID: 26343003.
      View in: PubMed
    28. Varkaris A, Corn PG, Parikh NU, Efstathiou E, Song JH, Lee YC, Aparicio A, Hoang AG, Gaur S, Thorpe L, Maity SN, Bar Eli M, Czerniak BA, Shao Y, Alauddin M, Lin SH, Logothetis CJ, Gallick GE. Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer. Clin Cancer Res. 2016 Jan 01; 22(1):107-21. PMID: 26272062; PMCID: PMC4703437 [Available on 01/01/17].
    29. Dhillon J, Liang Y, Kamat AM, Siefker-Radtke A, Dinney CP, Czerniak B, Guo CC. Urachal carcinoma: a pathologic and clinical study of 46 cases. Hum Pathol. 2015 Dec; 46(12):1808-14. PMID: 26364859; PMCID: PMC4824311 [Available on 12/01/16].
    30. Dadhania V, Czerniak B, Guo CC. Adenocarcinoma of the urinary bladder. Am J Clin Exp Urol. 2015; 3(2):51-63. PMID: 26309895; PMCID: PMC4539107.
    31. Sircar K, Yoo SY, Majewski T, Wani K, Patel LR, Voicu H, Torres-Garcia W, Verhaak RG, Tannir N, Karam JA, Jonasch E, Wood CG, Tamboli P, Baggerly KA, Aldape KD, Czerniak B. Biphasic components of sarcomatoid clear cell renal cell carcinomas are molecularly similar to each other, but distinct from, non-sarcomatoid renal carcinomas. J Pathol Clin Res. 2015 Oct; 1(4):212-24. PMID: 27499906; PMCID: PMC4939892.
    32. Singh RR, Murugan P, Patel LR, Voicu H, Yoo SY, Majewski T, Mehrotra M, Wani K, Tannir N, Karam JA, Jonasch E, Wood CG, Creighton CJ, Medeiros LJ, Broaddus RR, Tamboli P, Baggerly KA, Aldape KD, Czerniak B, Luthra R, Sircar K. Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy. Mod Pathol. 2015 Sep; 28(9):1225-35. PMID: 26111976.
      View in: PubMed
    33. McConkey DJ, Choi W, Ochoa A, Siefker-Radtke A, Czerniak B, Dinney CP. Therapeutic opportunities in the intrinsic subtypes of muscle-invasive bladder cancer. Hematol Oncol Clin North Am. 2015 Apr; 29(2):377-94, x-xi. PMID: 25836941.
      View in: PubMed
    34. Li W, Liang Y, Deavers MT, Kamat AM, Matin SF, Dinney CP, Czerniak B, Guo CC. Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants. Am J Clin Pathol. 2014 Dec; 142(6):864-71. PMID: 25389341.
      View in: PubMed
    35. Dinney CP, Hansel D, McConkey D, Shipley W, Hagan M, Dreicer R, Lerner S, Czerniak B, Waldman F, Groshen S, True LD, Petricoin E, Theodorescu D, Hruszkewycz A, Bajorin D. Novel neoadjuvant therapy paradigms for bladder cancer: results from the National Cancer Center Institute Forum. Urol Oncol. 2014 Nov; 32(8):1108-15. PMID: 25443274.
      View in: PubMed
    36. Willis DL, Fernandez MI, Dickstein RJ, Parikh S, Shah JB, Pisters LL, Guo CC, Henderson S, Czerniak BA, Grossman HB, Dinney CP, Kamat AM. Clinical outcomes of cT1 micropapillary bladder cancer. J Urol. 2015 Apr; 193(4):1129-34. PMID: 25254936; PMCID: PMC4687395.
    37. Apolo AB, Hoffman V, Kaag MG, Latini DM, Lee CT, Rosenberg JE, Knowles M, Theodorescu D, Czerniak BA, Efstathiou JA, Albert ML, Sridhar SS, Margulis V, Matin SF, Galsky MD, Hansel D, Kamat AM, Flaig TW, Smith AB, Messing E, Zipursky Quale D, Lotan Y. Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward. Urol Oncol. 2015 Feb; 33(2):53-64. PMID: 25065704.
      View in: PubMed
    38. Choi W, Czerniak B, Ochoa A, Su X, Siefker-Radtke A, Dinney C, McConkey DJ. Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer. Nat Rev Urol. 2014 Jul; 11(7):400-10. PMID: 24960601.
      View in: PubMed
    39. Liang Y, Heitzman J, Kamat AM, Dinney CP, Czerniak B, Guo CC. Differential expression of GATA-3 in urothelial carcinoma variants. Hum Pathol. 2014 Jul; 45(7):1466-72. PMID: 24745616.
      View in: PubMed
    40. Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, Roth B, Cheng T, Tran M, Lee IL, Melquist J, Bondaruk J, Majewski T, Zhang S, Pretzsch S, Baggerly K, Siefker-Radtke A, Czerniak B, Dinney CP, McConkey DJ. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell. 2014 Feb 10; 25(2):152-65. PMID: 24525232; PMCID: PMC4011497.
    41. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014 Mar 20; 507(7492):315-22. PMID: 24476821; PMCID: PMC3962515.
    42. Solomon DA, Kim JS, Bondaruk J, Shariat SF, Wang ZF, Elkahloun AG, Ozawa T, Gerard J, Zhuang D, Zhang S, Navai N, Siefker-Radtke A, Phillips JJ, Robinson BD, Rubin MA, Volkmer B, Hautmann R, Küfer R, Hogendoorn PC, Netto G, Theodorescu D, James CD, Czerniak B, Miettinen M, Waldman T. Frequent truncating mutations of STAG2 in bladder cancer. Nat Genet. 2013 Dec; 45(12):1428-30. PMID: 24121789; PMCID: PMC3875130.
    43. Stanton ML, Xiao L, Czerniak BA, Guo CC. Urothelial tumors of the urinary bladder in young patients: a clinicopathologic study of 59 cases. Arch Pathol Lab Med. 2013 Oct; 137(10):1337-41. PMID: 24079760; PMCID: PMC3927706.
    44. Ferdin J, Nishida N, Wu X, Nicoloso MS, Shah MY, Devlin C, Ling H, Shimizu M, Kumar K, Cortez MA, Ferracin M, Bi Y, Yang D, Czerniak B, Zhang W, Schmittgen TD, Voorhoeve MP, Reginato MJ, Negrini M, Davuluri RV, Kunej T, Ivan M, Calin GA. HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts. Cell Death Differ. 2013 Dec; 20(12):1675-87. PMID: 24037088; PMCID: PMC3824588.
    45. Culp SH, Dickstein RJ, Grossman HB, Pretzsch SM, Porten S, Daneshmand S, Cai J, Groshen S, Siefker-Radtke A, Millikan RE, Czerniak B, Navai N, Wszolek MF, Kamat AM, Dinney CP. Refining patient selection for neoadjuvant chemotherapy before radical cystectomy. J Urol. 2014 Jan; 191(1):40-7. PMID: 23911605; PMCID: PMC4158919.
    46. Tarrant WP, Czerniak BA, Guo CC. Relationship between primary and metastatic testicular germ cell tumors: a clinicopathologic analysis of 100 cases. Hum Pathol. 2013 Oct; 44(10):2220-6. PMID: 23856516.
      View in: PubMed
    47. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Jul 04; 499(7456):43-9. PMID: 23792563; PMCID: PMC3771322.
    48. Gust KM, McConkey DJ, Awrey S, Hegarty PK, Qing J, Bondaruk J, Ashkenazi A, Czerniak B, Dinney CP, Black PC. Fibroblast growth factor receptor 3 is a rational therapeutic target in bladder cancer. Mol Cancer Ther. 2013 Jul; 12(7):1245-54. PMID: 23657946.
      View in: PubMed
    49. Schweighofer CD, Coombes KR, Majewski T, Barron LL, Lerner S, Sargent RL, O'Brien S, Ferrajoli A, Wierda WG, Czerniak BA, Medeiros LJ, Keating MJ, Abruzzo LV. Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes. J Mol Diagn. 2013 Mar; 15(2):196-209. PMID: 23273604.
      View in: PubMed
    50. Lee S, Lee I, Jung Y, McConkey D, Czerniak B. In-frame cDNA library combined with protein complementation assay identifies ARL11-binding partners. PLoS One. 2012; 7(12):e52290. PMID: 23272234; PMCID: PMC3525598.
    51. Tran MN, Choi W, Wszolek MF, Navai N, Lee IL, Nitti G, Wen S, Flores ER, Siefker-Radtke A, Czerniak B, Dinney C, Barton M, McConkey DJ. The p63 protein isoform ?Np63a inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205. J Biol Chem. 2013 Feb 01; 288(5):3275-88. PMID: 23239884; PMCID: PMC3561548.
    52. Dayyani F, Czerniak BA, Sircar K, Munsell MF, Millikan RE, Dinney CP, Siefker-Radtke AO. Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis. J Urol. 2013 May; 189(5):1656-61. PMID: 23159581.
      View in: PubMed
    53. Majewski T, Spiess PE, Bondaruk J, Black P, Clarke C, Benedict W, Dinney CP, Grossman HB, Tang KS, Czerniak B. Detection of bladder cancer using proteomic profiling of urine sediments. PLoS One. 2012; 7(8):e42452. PMID: 22879988.
      View in: PubMed
    54. Alexandrescu S, Tatevian N, Czerniak BA, Covinsky MH, Burns NK, Brown RE. Morphoproteomics provides support for TGF-ß pathway signaling in the osteoclastogenesis and immune dysregulation of osteolytic Langerhans cell histiocytosis. Int J Clin Exp Pathol. 2012; 5(6):503-11. PMID: 22949932; PMCID: PMC3430113.
    55. Si Q, Dancer J, Stanton ML, Tamboli P, Ro JY, Czerniak BA, Shen SS, Guo CC. Small cell carcinoma of the kidney: a clinicopathologic study of 14 cases. Hum Pathol. 2011 Nov; 42(11):1792-8. PMID: 21733553.
      View in: PubMed
    56. Guo CC, Wang Y, Xiao L, Troncoso P, Czerniak BA. The relationship of TMPRSS2-ERG gene fusion between primary and metastatic prostate cancers. Hum Pathol. 2012 May; 43(5):644-9. PMID: 21937078; PMCID: PMC3880196.
    57. Sabichi AL, Lee JJ, Grossman HB, Liu S, Richmond E, Czerniak BA, De la Cerda J, Eagle C, Viner JL, Palmer JL, Lerner SP. A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer. Cancer Prev Res (Phila). 2011 Oct; 4(10):1580-9. PMID: 21881030; PMCID: PMC4028708.
    58. Chung W, Bondaruk J, Jelinek J, Lotan Y, Liang S, Czerniak B, Issa JP. Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments. Cancer Epidemiol Biomarkers Prev. 2011 Jul; 20(7):1483-91. PMID: 21586619; PMCID: PMC3132294.
    59. Diao L, Clarke CH, Coombes KR, Hamilton SR, Roth J, Mao L, Czerniak B, Baggerly KA, Morris JS, Fung ET, Bast RC. Reproducibility of SELDI Spectra Across Time and Laboratories. Cancer Inform. 2011 Mar 14; 10:45-64. PMID: 21552492; PMCID: PMC3085423.
    60. Duzkale H, Schweighofer CD, Coombes KR, Barron LL, Ferrajoli A, O'Brien S, Wierda WG, Pfeifer J, Majewski T, Czerniak BA, Jorgensen JL, Medeiros LJ, Freireich EJ, Keating MJ, Abruzzo LV. LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients. Blood. 2011 Apr 14; 117(15):4076-84. PMID: 21310924; PMCID: PMC3087532.
    61. Kumar R, Deaver MT, Czerniak BA, Madewell JE. Intraosseous hibernoma. Skeletal Radiol. 2011 May; 40(5):641-5. PMID: 21207023.
      View in: PubMed
    62. Dancer JY, Henry SP, Bondaruk J, Lee S, Ayala AG, de Crombrugghe B, Czerniak B. Expression of master regulatory genes controlling skeletal development in benign cartilage and bone forming tumors. Hum Pathol. 2010 Dec; 41(12):1788-93. PMID: 21078438; PMCID: PMC4012830.
    63. Guo CC, Dancer JY, Wang Y, Aparicio A, Navone NM, Troncoso P, Czerniak BA. TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate. Hum Pathol. 2011 Jan; 42(1):11-7. PMID: 21040948.
      View in: PubMed
    64. Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, Figueroa JD, Real FX, Van Den Berg D, Matullo G, Baris D, Thun M, Kiemeney LA, Vineis P, De Vivo I, Albanes D, Purdue MP, Rafnar T, Hildebrandt MA, Kiltie AE, Cussenot O, Golka K, Kumar R, Taylor JA, Mayordomo JI, Jacobs KB, Kogevinas M, Hutchinson A, Wang Z, Fu YP, Prokunina-Olsson L, Burdett L, Yeager M, Wheeler W, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Johnson A, Schwenn M, Karagas MR, Schned A, Andriole G, Grubb R, Black A, Jacobs EJ, Diver WR, Gapstur SM, Weinstein SJ, Virtamo J, Cortessis VK, Gago-Dominguez M, Pike MC, Stern MC, Yuan JM, Hunter DJ, McGrath M, Dinney CP, Czerniak B, Chen M, Yang H, Vermeulen SH, Aben KK, Witjes JA, Makkinje RR, Sulem P, Besenbacher S, Stefansson K, Riboli E, Brennan P, Panico S, Navarro C, Allen NE, Bueno-de-Mesquita HB, Trichopoulos D, Caporaso N, Landi MT, Canzian F, Ljungberg B, Tjonneland A, Clavel-Chapelon F, Bishop DT, Teo MT, Knowles MA, Guarrera S, Polidoro S, Ricceri F, Sacerdote C, Allione A, Cancel-Tassin G, Selinski S, Hengstler JG, Dietrich H, Fletcher T, Rudnai P, Gurzau E, Koppova K, Bolick SC, Godfrey A, Xu Z, Sanz-Velez JI, D García-Prats M, Sanchez M, Valdivia G, Porru S, Benhamou S, Hoover RN, Fraumeni JF, Silverman DT, Chanock SJ. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet. 2010 Nov; 42(11):978-84. PMID: 20972438.
      View in: PubMed
    65. Dhillon J, Tannir NM, Matin SF, Tamboli P, Czerniak BA, Guo CC. Thyroid-like follicular carcinoma of the kidney with metastases to the lungs and retroperitoneal lymph nodes. Hum Pathol. 2011 Jan; 42(1):146-50. PMID: 20971497; PMCID: PMC4163005.
    66. Estécio MR, Gallegos J, Vallot C, Castoro RJ, Chung W, Maegawa S, Oki Y, Kondo Y, Jelinek J, Shen L, Hartung H, Aplan PD, Czerniak BA, Liang S, Issa JP. Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer. Genome Res. 2010 Oct; 20(10):1369-82. PMID: 20716667; PMCID: PMC2945186.
    67. Merriman DJ, Deavers MT, Czerniak BA, Lin PP. Massive desmoplastic fibroblastoma with scapular invasion. Orthopedics. 2010 Aug 11; 33(8). PMID: 20704102.
      View in: PubMed
    68. McConkey DJ, Lee S, Choi W, Tran M, Majewski T, Lee S, Siefker-Radtke A, Dinney C, Czerniak B. Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression. Urol Oncol. 2010 Jul-Aug; 28(4):429-40. PMID: 20610280; PMCID: PMC2901550.
    69. Contreras AL, Punar M, Tamboli P, Tu SM, Pisters L, Moran C, Czerniak BA, Guo CC. Mediastinal germ cell tumors with an angiosarcomatous component: a report of 12 cases. Hum Pathol. 2010 Jun; 41(6):832-7. PMID: 20153508; PMCID: PMC4163004.
    70. Inamoto T, Czerniak BA, Dinney CP, Kamat AM. Cytoplasmic mislocalization of the orphan nuclear receptor Nurr1 is a prognostic factor in bladder cancer. Cancer. 2010 Jan 15; 116(2):340-6. PMID: 19908257.
      View in: PubMed
    71. Powers M, Zhang W, Lopez-Terrada D, Czerniak BA, Lazar AJ. The molecular pathology of sarcomas. Cancer Biomark. 2010; 9(1-6):475-91. PMID: 22112491.
      View in: PubMed
    72. Czerniak B. Molecular pathology and biomarkers of bladder cancer. Cancer Biomark. 2010; 9(1-6):159-76. PMID: 22112475.
      View in: PubMed
    73. Nicolas MM, Tamboli P, Gomez JA, Czerniak BA. Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases. Hum Pathol. 2010 May; 41(5):663-71. PMID: 20004935.
      View in: PubMed
    74. Wu X, Ye Y, Kiemeney LA, Sulem P, Rafnar T, Matullo G, Seminara D, Yoshida T, Saeki N, Andrew AS, Dinney CP, Czerniak B, Zhang ZF, Kiltie AE, Bishop DT, Vineis P, Porru S, Buntinx F, Kellen E, Zeegers MP, Kumar R, Rudnai P, Gurzau E, Koppova K, Mayordomo JI, Sanchez M, Saez B, Lindblom A, de Verdier P, Steineck G, Mills GB, Schned A, Guarrera S, Polidoro S, Chang SC, Lin J, Chang DW, Hale KS, Majewski T, Grossman HB, Thorlacius S, Thorsteinsdottir U, Aben KK, Witjes JA, Stefansson K, Amos CI, Karagas MR, Gu J. Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet. 2009 Sep; 41(9):991-5. PMID: 19648920; PMCID: PMC3313685.
    75. Guo CC, Punar M, Contreras AL, Tu SM, Pisters L, Tamboli P, Czerniak B. Testicular germ cell tumors with sarcomatous components: an analysis of 33 cases. Am J Surg Pathol. 2009 Aug; 33(8):1173-8. PMID: 19561445; PMCID: PMC3812063.
    76. Guo CC, Gomez E, Tamboli P, Bondaruk JE, Kamat A, Bassett R, Dinney CP, Czerniak BA. Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases. Hum Pathol. 2009 Oct; 40(10):1448-52. PMID: 19454359.
      View in: PubMed
    77. Guo CC, Zuo G, Cao D, Troncoso P, Czerniak BA. Prostate cancer of transition zone origin lacks TMPRSS2-ERG gene fusion. Mod Pathol. 2009 Jul; 22(7):866-71. PMID: 19396154.
      View in: PubMed
    78. Kim J, Jonasch E, Alexander A, Short JD, Cai S, Wen S, Tsavachidou D, Tamboli P, Czerniak BA, Do KA, Wu KJ, Marlow LA, Wood CG, Copland JA, Walker CL. Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma. Clin Cancer Res. 2009 Jan 01; 15(1):81-90. PMID: 19118035; PMCID: PMC3030253.
    79. Guo CC, Tamboli P, Czerniak B. Micropapillary variant of urothelial carcinoma in the upper urinary tract: a clinicopathologic study of 11 cases. Arch Pathol Lab Med. 2009 Jan; 133(1):62-6. PMID: 19123738.
      View in: PubMed
    80. Tsao CC, Teh BT, Jonasch E, Shreiber-Agus N, Efstathiou E, Hoang A, Czerniak B, Logothetis C, Corn PG. Inhibition of Mxi1 suppresses HIF-2alpha-dependent renal cancer tumorigenesis. Cancer Biol Ther. 2008 Oct; 7(10):1619-27. PMID: 19018165.
      View in: PubMed
    81. Brait M, Begum S, Carvalho AL, Dasgupta S, Vettore AL, Czerniak B, Caballero OL, Westra WH, Sidransky D, Hoque MO. Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer. Cancer Epidemiol Biomarkers Prev. 2008 Oct; 17(10):2786-94. PMID: 18843024; PMCID: PMC2778751.
    82. Park HS, Park WS, Bondaruk J, Tanaka N, Katayama H, Lee S, Spiess PE, Steinberg JR, Wang Z, Katz RL, Dinney C, Elias KJ, Lotan Y, Naeem RC, Baggerly K, Sen S, Grossman HB, Czerniak B. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection. J Natl Cancer Inst. 2008 Oct 01; 100(19):1401-11. PMID: 18812553; PMCID: PMC2720731.
    83. Shivapurkar N, Stastny V, Okumura N, Girard L, Xie Y, Prinsen C, Thunnissen FB, Wistuba II, Czerniak B, Frenkel E, Roth JA, Liloglou T, Xinarianos G, Field JK, Minna JD, Gazdar AF. Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene. Cancer Res. 2008 Sep 15; 68(18):7448-56. PMID: 18794132; PMCID: PMC2849650.
    84. Harris LD, De La Cerda J, Tuziak T, Rosen D, Xiao L, Shen Y, Sabichi AL, Czerniak B, Grossman HB. Analysis of the expression of biomarkers in urinary bladder cancer using a tissue microarray. Mol Carcinog. 2008 Sep; 47(9):678-85. PMID: 18288642; PMCID: PMC4321940.
    85. Wang WL, Mayordomo E, Czerniak BA, Abruzzo LV, Dal Cin P, Araujo DM, Lev DC, López-Terrada D, Lazar AJ. Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma. Mod Pathol. 2008 Nov; 21(11):1303-10. PMID: 18587326.
      View in: PubMed
    86. Ricketts R, Tamboli P, Czerniak B, Guo CC. Tumor-to-tumor metastasis: report of 2 cases of metastatic carcinoma to angiomyolipoma of the kidney. Arch Pathol Lab Med. 2008 Jun; 132(6):1016-20. PMID: 18517262.
      View in: PubMed
    87. Majewski T, Lee S, Jeong J, Yoon DS, Kram A, Kim MS, Tuziak T, Bondaruk J, Lee S, Park WS, Tang KS, Chung W, Shen L, Ahmed SS, Johnston DA, Grossman HB, Dinney CP, Zhou JH, Harris RA, Snyder C, Filipek S, Narod SA, Watson P, Lynch HT, Gazdar A, Bar-Eli M, Wu XF, McConkey DJ, Baggerly K, Issa JP, Benedict WF, Scherer SE, Czerniak B. Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy. Lab Invest. 2008 Jul; 88(7):694-721. PMID: 18458673; PMCID: PMC2849658.
    88. Shivapurkar N, Stastny V, Xie Y, Prinsen C, Frenkel E, Czerniak B, Thunnissen FB, Minna JD, Gazdar AF. Differential methylation of a short CpG-rich sequence within exon 1 of TCF21 gene: a promising cancer biomarker assay. Cancer Epidemiol Biomarkers Prev. 2008 Apr; 17(4):995-1000. PMID: 18398044; PMCID: PMC2762937.
    89. Katayama H, Sasai K, Czerniak BA, Carter JL, Sen S. Aurora-A kinase phosphorylation of Aurora-A kinase interacting protein (AIP) and stabilization of the enzyme-substrate complex. J Cell Biochem. 2007 Dec 01; 102(5):1318-31. PMID: 17957726.
      View in: PubMed
    90. Kassouf W, Black PC, Tuziak T, Bondaruk J, Lee S, Brown GA, Adam L, Wei C, Baggerly K, Bar-Eli M, McConkey D, Czerniak B, Dinney CP. Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer. J Urol. 2008 Jan; 179(1):353-8. PMID: 18006009; PMCID: PMC2680144.
    91. Lee S, Jeong J, Majewski T, Scherer SE, Kim MS, Tuziak T, Tang KS, Baggerly K, Grossman HB, Zhou JH, Shen L, Bondaruk J, Ahmed SS, Samanta S, Spiess P, Wu X, Filipek S, McConkey D, Bar-Eli M, Issa JP, Benedict WF, Czerniak B. Forerunner genes contiguous to RB1 contribute to the development of in situ neoplasia. Proc Natl Acad Sci U S A. 2007 Aug 21; 104(34):13732-7. PMID: 17702869; PMCID: PMC1949496.
    92. Kassouf W, Spiess PE, Siefker-Radtke A, Swanson D, Grossman HB, Kamat AM, Munsell MF, Guo CC, Czerniak BA, Dinney CP. Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience. Cancer. 2007 Aug 15; 110(4):764-9. PMID: 17614317.
      View in: PubMed
    93. Villares GJ, Zigler M, Blehm K, Bogdan C, McConkey D, Colin D, Bar-Eli M. Targeting EGFR in bladder cancer. World J Urol. 2007 Dec; 25(6):573-9. PMID: 17690890.
      View in: PubMed
    94. Spiess PE, Tuziak T, Tibbs RF, Bassett R, Tamboli P, Brown GA, Grossman HB, Ayala AG, Czerniak B. Pseudosarcomatous and sarcomatous proliferations of the bladder. Hum Pathol. 2007 May; 38(5):753-61. PMID: 17306332.
      View in: PubMed
    95. Tuziak T, Spiess PE, Abrahams NA, Wrona A, Tu SM, Czerniak B. Multilocular cystadenoma and cystadenocarcinoma of the prostate. Urol Oncol. 2007 Jan-Feb; 25(1):19-25. PMID: 17208134.
      View in: PubMed
    96. Spiess PE, Kassouf W, Steinberg JR, Tuziak T, Hernandez M, Tibbs RF, Czerniak B, Kamat AM, Dinney CP, Grossman HB. Review of the M.D. Anderson experience in the treatment of bladder sarcoma. Urol Oncol. 2007 Jan-Feb; 25(1):38-45. PMID: 17208137.
      View in: PubMed
    97. Lazar A, Abruzzo LV, Pollock RE, Lee S, Czerniak B. Molecular diagnosis of sarcomas: chromosomal translocations in sarcomas. Arch Pathol Lab Med. 2006 Aug; 130(8):1199-207. PMID: 16879024.
      View in: PubMed
    98. Blehm KN, Spiess PE, Bondaruk JE, Dujka ME, Villares GJ, Zhao YJ, Bogler O, Aldape KD, Grossman HB, Adam L, McConkey DJ, Czerniak BA, Dinney CP, Bar-Eli M. Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy. Clin Cancer Res. 2006 Aug 01; 12(15):4671-7. PMID: 16899617.
      View in: PubMed
    99. Spiess PE, Czerniak B. Dual-track pathway of bladder carcinogenesis: practical implications. Arch Pathol Lab Med. 2006 Jun; 130(6):844-52. PMID: 16740038.
      View in: PubMed
    100. Spiess PE, Kassouf W, Brown G, Highshaw R, Wang X, Do KA, Kamat AM, Czerniak B, Dinney CP, Grossman HB. Immediate versus staged urethrectomy in patients at high risk of urethral recurrence: is there a benefit to either approach? Urology. 2006 Mar; 67(3):466-71. PMID: 16527559.
      View in: PubMed
    101. Kim MS, Jeong J, Majewski T, Kram A, Yoon DS, Zhang RD, Li JZ, Ptaszynski K, Kuang TC, Zhou JH, Sathyanarayana UG, Tuziak T, Johnston DA, Grossman HB, Gazdar AF, Scherer SE, Benedict WF, Czerniak B. Evidence for alternative candidate genes near RB1 involved in clonal expansion of in situ urothelial neoplasia. Lab Invest. 2006 Feb; 86(2):175-90. PMID: 16402033.
      View in: PubMed
    102. Spiess PE, Tuziak T, Kassouf W, Grossman HB, Czerniak B. Malignant mesothelioma of the tunica vaginalis. Urology. 2005 Aug; 66(2):397-401. PMID: 16040098.
      View in: PubMed
    103. Huo L, Lai S, Gladish G, Czerniak BA, Moran CA. Pulmonary artery angiosarcoma: a clinicopathologic and radiological correlation. Ann Diagn Pathol. 2005 Aug; 9(4):209-14. PMID: 16084454.
      View in: PubMed
    104. Tuziak T, Jeong J, Majewski T, Kim MS, Steinberg J, Wang Z, Yoon DS, Kuang TC, Baggerly K, Johnston D, Czerniak B. High-resolution whole-organ mapping with SNPs and its significance to early events of carcinogenesis. Lab Invest. 2005 May; 85(5):689-701. PMID: 15908911.
      View in: PubMed
    105. Kim JH, Tuziak T, Hu L, Wang Z, Bondaruk J, Kim M, Fuller G, Dinney C, Grossman HB, Baggerly K, Zhang W, Czerniak B. Alterations in transcription clusters underlie development of bladder cancer along papillary and nonpapillary pathways. Lab Invest. 2005 Apr; 85(4):532-49. PMID: 15778693.
      View in: PubMed
    106. Kamat AM, Carpenter SM, Czerniak BA, Pisters LL. Metastatic penile cancer in a young Caucasian male: impact of delayed diagnosis. Urol Oncol. 2005 Mar-Apr; 23(2):130-1. PMID: 15869998.
      View in: PubMed
    107. Shigematsu H, Suzuki M, Takahashi T, Miyajima K, Toyooka S, Shivapurkar N, Tomlinson GE, Mastrangelo D, Pass HI, Brambilla E, Sathyanarayana UG, Czerniak B, Fujisawa T, Shimizu N, Gazdar AF. Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies. Int J Cancer. 2005 Feb 10; 113(4):600-4. PMID: 15472908.
      View in: PubMed
    108. Shao L, Lerner SL, Bondaruk J, Czerniak BA, Zeng X, Grossman HB, Spitz MR, Wu X. Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer. Genes Chromosomes Cancer. 2004 Dec; 41(4):379-89. PMID: 15390184.
      View in: PubMed
    109. Dinney CP, McConkey DJ, Millikan RE, Wu X, Bar-Eli M, Adam L, Kamat AM, Siefker-Radtke AO, Tuziak T, Sabichi AL, Grossman HB, Benedict WF, Czerniak B. Focus on bladder cancer. Cancer Cell. 2004 Aug; 6(2):111-6. PMID: 15324694.
      View in: PubMed
    110. Sathyanarayana UG, Maruyama R, Padar A, Suzuki M, Bondaruk J, Sagalowsky A, Minna JD, Frenkel EP, Grossman HB, Czerniak B, Gazdar AF. Molecular detection of noninvasive and invasive bladder tumor tissues and exfoliated cells by aberrant promoter methylation of laminin-5 encoding genes. Cancer Res. 2004 Feb 15; 64(4):1425-30. PMID: 14973053.
      View in: PubMed
    111. Slaton JW, Millikan R, Inoue K, Karashima T, Czerniak B, Shen Y, Yang Y, Benedict WF, Dinney CP. Correlation of metastasis related gene expression and relapse-free survival in patients with locally advanced bladder cancer treated with cystectomy and chemotherapy. J Urol. 2004 Feb; 171(2 Pt 1):570-4. PMID: 14713761.
      View in: PubMed
    112. Katayama H, Sasai K, Kawai H, Yuan ZM, Bondaruk J, Suzuki F, Fujii S, Arlinghaus RB, Czerniak BA, Sen S. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet. 2004 Jan; 36(1):55-62. PMID: 14702041.
      View in: PubMed
    113. Abrahams NA, Ayala AG, Czerniak B. Chromophobe renal cell carcinoma with sarcomatoid transformation. Ann Diagn Pathol. 2003 Oct; 7(5):296-9. PMID: 14571432.
      View in: PubMed
    114. Czerniak B. Pathologic and molecular aspects of soft tissue sarcomas. Surg Oncol Clin N Am. 2003 Apr; 12(2):263-303, v. PMID: 12916456.
      View in: PubMed
    115. Wehrli BM, Huang W, De Crombrugghe B, Ayala AG, Czerniak B. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors. Hum Pathol. 2003 Mar; 34(3):263-9. PMID: 12673561.
      View in: PubMed
    116. Sen S, Zhou H, Zhang RD, Yoon DS, Vakar-Lopez F, Ito S, Jiang F, Johnston D, Grossman HB, Ruifrok AC, Katz RL, Brinkley W, Czerniak B. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J Natl Cancer Inst. 2002 Sep 04; 94(17):1320-9. PMID: 12208897.
      View in: PubMed
    117. Yamashita M, Rosser CJ, Zhou JH, Zhang XQ, Connor RJ, Engler H, Maneval DC, Karashima T, Czerniak BA, Dinney CP, Benedict WF. Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer. Cancer Gene Ther. 2002 Aug; 9(8):687-91. PMID: 12136430.
      View in: PubMed
    118. Estrada EG, Ayala AG, Lewis V, Czerniak B, Valerie L. Dedifferentiated chondrosarcoma with a noncartilaginous component mimicking a conventional giant cell tumor of bone. Ann Diagn Pathol. 2002 Jun; 6(3):159-63. PMID: 12089726.
      View in: PubMed
    119. Maruyama R, Toyooka S, Toyooka KO, Harada K, Virmani AK, Zöchbauer-Müller S, Farinas AJ, Vakar-Lopez F, Minna JD, Sagalowsky A, Czerniak B, Gazdar AF. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res. 2001 Dec 15; 61(24):8659-63. PMID: 11751381.
      View in: PubMed
    120. Merchant SH, Amin MB, Tamboli P, Ro J, Ordóñez NG, Ayala AG, Czerniak BA, Ro JY. Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas. Am J Surg Pathol. 2001 Dec; 25(12):1515-9. PMID: 11717541.
      View in: PubMed
    121. Yoon DS, Li L, Zhang RD, Kram A, Ro JY, Johnston D, Grossman HB, Scherer S, Czerniak B. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease. Oncogene. 2001 Aug 16; 20(36):5005-14. PMID: 11526485.
      View in: PubMed
    122. Kram A, Li L, Zhang RD, Yoon DS, Ro JY, Johnston D, Grossman HB, Scherer S, Czerniak B. Mapping and genome sequence analysis of chromosome 5 regions involved in bladder cancer progression. Lab Invest. 2001 Jul; 81(7):1039-48. PMID: 11454992.
      View in: PubMed
    123. Eftekhari F, Ater JL, Ayala AG, Czerniak BA. Case report: Calcifying fibrous pseudotumour of the adrenal gland. Br J Radiol. 2001 May; 74(881):452-4. PMID: 11388995.
      View in: PubMed
    124. Gazdar AF, Czerniak B. Filling the void: urinary markers for bladder cancer risk and diagnosis. J Natl Cancer Inst. 2001 Mar 21; 93(6):413-5. PMID: 11259458.
      View in: PubMed
    125. Izawa JI, Slaton JW, Kedar D, Karashima T, Perrotte P, Czerniak B, Grossman HB, Dinney CP. Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder. Oncol Rep. 2001 Jan-Feb; 8(1):9-15. PMID: 11115562.
      View in: PubMed
    126. Hoang MP, Suarez PA, Donner LR, Y Ro J, Ordóñez NG, Ayala AG, Czerniak B. Mesenchymal Chondrosarcoma: A Small Cell Neoplasm with Polyphenotypic Differentiation. Int J Surg Pathol. 2000 Oct; 8(4):291-301. PMID: 11494006.
      View in: PubMed
    127. Häckel CG, Krueger S, Grote HJ, Oshiro Y, Hodges S, Johnston DA, Johnson ME, Roessner A, Ayala AG, Czerniak B. Overexpression of cathepsin B and urokinase plasminogen activator is associated with increased risk of recurrence and metastasis in patients with chondrosarcoma. Cancer. 2000 Sep 01; 89(5):995-1003. PMID: 10964329.
      View in: PubMed
    128. Haeckel C, Krueger S, Kuester D, Ostertag H, Samii M, Buehling F, Broemme D, Czerniak B, Roessner A. Expression of cathepsin K in chordoma. Hum Pathol. 2000 Jul; 31(7):834-40. PMID: 10923921.
      View in: PubMed
    129. Chan LL, Czerniak BA, Ginsberg LE. Radiation-induced osteosarcoma after bilateral childhood retinoblastoma. AJR Am J Roentgenol. 2000 May; 174(5):1288. PMID: 10789778.
      View in: PubMed
    130. Czerniak B, Li L, Chaturvedi V, Ro JY, Johnston DA, Hodges S, Benedict WF. Genetic modeling of human urinary bladder carcinogenesis. Genes Chromosomes Cancer. 2000 Apr; 27(4):392-402. PMID: 10719370.
      View in: PubMed
    131. Vakar-López F, Ayala AG, Raymond AK, Czerniak B. Epithelial Phenotype in Ewing's Sarcoma/Primitive Neuroectodermal Tumor. Int J Surg Pathol. 2000 Jan; 8(1):59-65. PMID: 11493965.
      View in: PubMed
    132. Haeckel C, Ayala AG, Radig K, Raymond AK, Roessner A, Czerniak B. Protease expression in dedifferentiated parosteal osteosarcoma. Arch Pathol Lab Med. 1999 Mar; 123(3):213-21. PMID: 10086509.
      View in: PubMed
    133. Benedict WF, Lerner SP, Zhou J, Shen X, Tokunaga H, Czerniak B. Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer. Oncogene. 1999 Feb 04; 18(5):1197-203. PMID: 10022125.
      View in: PubMed
    134. Czerniak B, Chaturvedi V, Li L, Hodges S, Johnston D, Roy JY, Luthra R, Logothetis C, Von Eschenbach AC, Grossman HB, Benedict WF, Batsakis JG. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer. Oncogene. 1999 Feb 04; 18(5):1185-96. PMID: 10022124.
      View in: PubMed
    135. Oshiro Y, Chaturvedi V, Hayden D, Nazeer T, Johnson M, Johnston DA, Ordóñez NG, Ayala AG, Czerniak B. Altered p53 is associated with aggressive behavior of chondrosarcoma: a long term follow-up study. Cancer. 1998 Dec 01; 83(11):2324-34. PMID: 9840532.
      View in: PubMed
    136. Kaufman AM, Slaton JW, Czerniak BA, Grossman HB. Transitional cell carcinoma of the bladder with involvement of vasa deferentia. J Urol. 1998 Jan; 159(1):204-5. PMID: 9400477.
      View in: PubMed
    137. Pollack A, Wu CS, Czerniak B, Zagars GK, Benedict WF, McDonnell TJ. Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer. Clin Cancer Res. 1997 Oct; 3(10):1823-9. PMID: 9815569.
      View in: PubMed
    138. Pollack A, Czerniak B, Zagars GK, Hu SX, Wu CS, Dinney CP, Chyle V, Benedict WF. Retinoblastoma protein expression and radiation response in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys. 1997 Oct 01; 39(3):687-95. PMID: 9336151.
      View in: PubMed
    139. Chaturvedi V, Li L, Hodges S, Johnston D, Ro JY, Logothetis C, von Eschenbach AC, Batsakis JG, Czerniak B. Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia. Oncogene. 1997 May 01; 14(17):2059-70. PMID: 9160886.
      View in: PubMed
    140. Häckel C, Czerniak B, Ayala AG, Radig K, Roessner A. Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma. Cancer. 1997 Jan 01; 79(1):53-8. PMID: 8988726.
      View in: PubMed
    141. Chyle V, Pollack A, Czerniak B, Stephens LC, Zagars GK, Terry NH, Meyn RE. Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys. 1996 May 01; 35(2):281-7. PMID: 8635934.
      View in: PubMed
    142. Wu CS, Pollack A, Czerniak B, Chyle V, Zagars GK, Dinney CP, Hu SX, Benedict WF. Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy. Urology. 1996 Mar; 47(3):305-10. PMID: 8633392.
      View in: PubMed
    143. Cook PD, Czerniak B, Chan JK, Mackay B, Ordóñez NG, Ayala AG, Rosai J. Nodular spindle-cell vascular transformation of lymph nodes. A benign process occurring predominantly in retroperitoneal lymph nodes draining carcinomas that can simulate Kaposi's sarcoma or metastatic tumor. Am J Surg Pathol. 1995 Sep; 19(9):1010-20. PMID: 7661274.
      View in: PubMed
    144. Simms WW, Ordóñez NG, Johnston D, Ayala AG, Czerniak B. p53 expression in dedifferentiated chondrosarcoma. Cancer. 1995 Jul 15; 76(2):223-7. PMID: 8625095.
      View in: PubMed
    145. Coughlan B, Feliz A, Ishida T, Czerniak B, Dorfman HD. p53 expression and DNA ploidy of cartilage lesions. Hum Pathol. 1995 Jun; 26(6):620-4. PMID: 7774891.
      View in: PubMed
    146. Czerniak B, Rosai J. Role of cytology in intraoperative diagnosis. A practical guide. Pathol Annu. 1995; 30 Pt 2:83-102. PMID: 8570281.
      View in: PubMed
    147. Dorfman HD, Czerniak B. Bone cancers. Cancer. 1995 Jan 01; 75(1 Suppl):203-10. PMID: 8000997.
      View in: PubMed
    148. Czerniak B, Cohen GL, Etkind P, Deitch D, Simmons H, Herz F, Koss LG. Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas. Hum Pathol. 1992 Nov; 23(11):1199-204. PMID: 1427748.
      View in: PubMed
    149. Czerniak B, Herz F, Wersto RP, Koss LG. Asymmetric distribution of oncogene products at mitosis. Proc Natl Acad Sci U S A. 1992 Jun 01; 89(11):4860-3. PMID: 1350677; PMCID: PMC49187.
    150. Koss LG, Czerniak B. Image analysis and flow cytometry of tumors of prostate and bladder; with a comment on molecular biology of urothelial tumors. Monogr Pathol. 1992; (34):112-28. PMID: 1406738.
      View in: PubMed
    151. Herz F, Czerniak B, Deitch D, Wersto RP, Simmons DA, Koss LG. Protein expression in relation to the cell cycle of exponentially growing human prostatic epithelial cells. Cell Prolif. 1991 May; 24(3):321-30. PMID: 2039807.
      View in: PubMed
    152. Biology and management of bladder cancer. N Engl J Med. 1991 Jan 10; 324(2):125-6. PMID: 1984179.
      View in: PubMed
    153. Czerniak B, Deitch D, Simmons H, Etkind P, Herz F, Koss LG. Ha-ras gene codon 12 mutation and DNA ploidy in urinary bladder carcinoma. Br J Cancer. 1990 Nov; 62(5):762-3. PMID: 2245167; PMCID: PMC1971513.
    154. Czerniak B, Herz F, Wersto RP, Alster P, Puszkin E, Schwarz E, Koss LG. Quantitation of oncogene products by computer-assisted image analysis and flow cytometry. J Histochem Cytochem. 1990 Apr; 38(4):463-6. PMID: 1969431.
      View in: PubMed
    155. Czerniak B, Rojas-Corona RR, Dorfman HD. Morphologic diversity of long bone adamantinoma. The concept of differentiated (regressing) adamantinoma and its relationship to osteofibrous dysplasia. Cancer. 1989 Dec 01; 64(11):2319-34. PMID: 2804923.
      View in: PubMed
    156. Czerniak B, Herz F, Gorczyca W, Koss LG. Expression of ras oncogene p21 protein in early gastric carcinoma and adjacent gastric epithelia. Cancer. 1989 Oct 01; 64(7):1467-73. PMID: 2550123.
      View in: PubMed
    157. Koss LG, Czerniak B, Herz F, Wersto RP. Flow cytometric measurements of DNA and other cell components in human tumors: a critical appraisal. Hum Pathol. 1989 Jun; 20(6):528-48. PMID: 2470666.
      View in: PubMed
    158. Czerniak B, Chen R, Tuziak T, Markiewski M, Kram A, Gorczyca W, Deitch D, Herz F, Koss LG. Expression of ras oncogene p21 protein in relation to regional spread of human breast carcinomas. Cancer. 1989 May 15; 63(10):2008-13. PMID: 2467732.
      View in: PubMed
    159. Czerniak B, Darzynkiewicz Z, Herz F, Wersto RP, Koss LG. Flow cytometry in clinical oncology: cell cycle and DNA ploidy in assessing tumor behavior. Mater Med Pol. 1989 Jan-Mar; 21(1):3-9. PMID: 2699343.
      View in: PubMed
    160. Czerniak B, Tuziak T, Markiewski M, Kram A, Gorczyca W, Herz F, Koss LG. [Expression of ras oncogenes in early and advanced breast cancer in women]. Nowotwory. 1988 May-Jun; 38(3):145-51. PMID: 3072522.
      View in: PubMed
    161. Gorczyca W, Lubinski J, Czerniak B. [Lymphoma of the breast detected by cytological examination]. Patol Pol. 1988 Jan-Mar; 39(1):66-70. PMID: 3412823.
      View in: PubMed
    162. Czerniak B, Eppich EM, Gorczyca W, Herz F, Koss LG. [Cytometric measurements of DNA ploidy in cancer of the large intestine]. Patol Pol. 1988 Jan-Mar; 39(1):1-12. PMID: 3412818.
      View in: PubMed
    163. Czerniak B, Herz F, Koss LG, Schlom J. ras oncogene p21 as a tumor marker in the cytodiagnosis of gastric and colonic carcinomas. Cancer. 1987 Nov 15; 60(10):2432-6. PMID: 3311346.
      View in: PubMed
    164. Czerniak B, Herz F, Wersto RP, Koss LG. Modification of Ha-ras oncogene p21 expression and cell cycle progression in the human colonic cancer cell line HT-29. Cancer Res. 1987 Jun 01; 47(11):2826-30. PMID: 3105868.
      View in: PubMed
    165. Czerniak B, Herz F, Wersto RP, Koss LG. Expression of Ha-ras oncogene p21 protein in relation to the cell cycle of cultured human tumor cells. Am J Pathol. 1987 Mar; 126(3):411-6. PMID: 3548406; PMCID: PMC1899652.
    166. Czerniak B, Herz F, Koss LG. DNA distribution patterns in early gastric carcinomas. A Feulgen cytometric study of gastric brush smears. Cancer. 1987 Jan 01; 59(1):113-7. PMID: 2431753.
      View in: PubMed
    167. Woyke S, Gorczyca W, Czerniak B, Depczynska A, Marlicz K. [Use of cytological methods in the diagnosis of cancer of the esophagus and cardia]. Nowotwory. 1986 Apr-Jun; 36(2):98-105. PMID: 3786167.
      View in: PubMed
    168. Czerniak B, Czerniak E, Marzecki Z. [Usefulness of fine-needle aspiration biopsy of lymph nodes in the diagnosis of Hodgkin's disease]. Nowotwory. 1986 Jan-Mar; 36(1):12-6. PMID: 3786153.
      View in: PubMed
    169. Czerniak B, Woyke S, Marlicz K. [Cytodiagnosis of early stomach cancer]. Patol Pol. 1986 Jan-Mar; 37(1):1-7. PMID: 3029654.
      View in: PubMed
    170. Czerniak B, Woyke S, Marlicz K. [Cytological-histological correlations in stomach cancer]. Patol Pol. 1985 Jul-Sep; 36(3):217-28. PMID: 3012446.
      View in: PubMed
    171. Czerniak B, Papenhausen PR, Herz F, Koss LG. Flow cytometric identification of cancer cells in effusions with Ca1 monoclonal antibody. Cancer. 1985 Jun 15; 55(12):2783-8. PMID: 3888371.
      View in: PubMed
    172. Czerniak B, Koss LG. Expression of Ca antigen on human urinary bladder tumors. Cancer. 1985 May 15; 55(10):2380-3. PMID: 3886123.
      View in: PubMed
    173. Czerniak B, Woyke S, Daniel B, Krzysztolik Z, Koss LG. Diagnosis of orbital tumors by aspiration biopsy guided by computerized tomography. Cancer. 1984 Dec 01; 54(11):2385-9. PMID: 6498730.
      View in: PubMed
    174. Czerniak B, Darzynkiewicz Z, Staiano-Coico L, Herz F, Koss LG. Expression of Ca antigen in relation to cell cycle in cultured human tumor cells. Cancer Res. 1984 Oct; 44(10):4342-6. PMID: 6432310.
      View in: PubMed
    175. Czerniak B, Koss LG, Sherman A. Nuclear pores and DNA ploidy in human bladder carcinomas. Cancer Res. 1984 Sep; 44(9):3752-6. PMID: 6744293.
      View in: PubMed
    176. Czerniak B, Marlicz K. Surface coat of enterocytes in chronic duodenitis. Mater Med Pol. 1984 Jan-Mar; 16(1):9-14. PMID: 6527574.
      View in: PubMed
    177. Czerniak B. Ultrastructure of the surface coat of the mesothelial and cancer cells from human effusions. Mater Med Pol. 1984 Jan-Mar; 16(1):3-7. PMID: 6527570.
      View in: PubMed
    178. Krzystolik Z, Czerniak B, Woyke S, Daniel B. [Use of thin-needle aspiration biopsy under computerized tomography control in the diagnosis of orbital tumors]. Pol Przegl Radiol. 1983 May-Jun; 47(3):185-8. PMID: 6369271.
      View in: PubMed
    179. Czerniak B, Woyke S, Domagala W, Krzysztolik Z. Fine needle aspiration cytology of intraocular malignant melanoma. Acta Cytol. 1983 Mar-Apr; 27(2):157-65. PMID: 6573087.
      View in: PubMed
    180. Starzynska T, Marlicz K, Depczynska A, Woyke S, Czerniak B. [Endoscopy with guided biopsy and cytological examination in the preoperative diagnosis of cancer of the upper digestive tract]. Pol Arch Med Wewn. 1983 Jan; 69(1):47-51. PMID: 6193500.
      View in: PubMed
    181. Krzystolik Z, Czerniak B, Woyke S. [Diagnosis of intraocular melanoma by thin-needle aspiration biopsy]. Klin Oczna. 1982 Sep; 84(9):279-82. PMID: 7162114.
      View in: PubMed
    182. Czerniak B, Woyke S, Lukaszyk I. The intercellular junctions of the cancer cells from human effusions. Acta Med Pol. 1981; 22(3):217-29. PMID: 7348091.
      View in: PubMed
    183. Woyke S, Domagala W, Czerniak B, Strokowska M. Fine needle aspiration cytology of malignant melanoma of the skin. Acta Cytol. 1980 Nov-Dec; 24(6):529-38. PMID: 6934680.
      View in: PubMed
    184. Czerniak B, Woyke S. Cell surface material of the mesothelial and cancer cells from human effusions. Acta Med Pol. 1980; 21(4):313-4. PMID: 6166152.
      View in: PubMed
    185. Lubinski J, Woyke S, Czerniak B. Concanavalin A distribution on the surface of the mesothelial and cancer cells from human effusions. Electron and fluorescent microscopic observations. Acta Med Pol. 1980; 21(4):377-8. PMID: 7246250.
      View in: PubMed
    186. Czerniak B, Jaroszewicz A, Solecki J. [Ultrastructure of the skeletal muscles in myotonia congenita]. Neuropatol Pol. 1979 Jul-Sep; 17(3):477-85. PMID: 503320.
      View in: PubMed
    187. Marlicz K, Czerniak B, Szymanski Z. [Duodenitis diagnosed by means of duodenoscopy: personal observations]. Pol Arch Med Wewn. 1979 Mar; 61(3):187-94. PMID: 440987.
      View in: PubMed
    188. Domagala W, Czerniak B, Woyke S. Distribution of surface coat on human cancer cells from body cavity fluids. A scanning electron microscopic study. Acta Med Pol. 1979; 20(4):377-8. PMID: 546091.
      View in: PubMed
    189. Woyke S, Czerniak B, Lukaszyk I. Changes in tight junction of the cancer cells from human effusions. Acta Med Pol. 1979; 20(4):475-6. PMID: 546123.
      View in: PubMed
    190. Woyke S, Czerniak B. Fine needle aspiration cytology of metastatic myxopapillary ependymoma. Acta Med Pol. 1979; 20(1):47-8. PMID: 495211.
      View in: PubMed
    191. Woyke S, Czerniak B, Lukaszyk I. Application of freeze-fractured replicas for evaluation of nuclear envelope of malignant cells from human effusions. Acta Med Pol. 1979; 20(4):477. PMID: 546124.
      View in: PubMed
    192. Lubinski J, Czerniak B. Distribution and movement of concanavalin-A receptors on the surface of cancer cells from human effusions. Acta Med Pol. 1979; 20(4):429-30. PMID: 546110.
      View in: PubMed
    193. Woyke S, Czerniak B. Fine needle aspiration cytology of metastatic myxopapillary ependymoma. Acta Cytol. 1978 Sep-Oct; 22(5):312-5. PMID: 281836.
      View in: PubMed
    194. Czerniak B, Woyke S, Cecerko J. [Ultrastructure of ependymoma myxopapillare]. Neurol Neurochir Pol. 1978 Mar-Apr; 12(2):173-8. PMID: 673124.
      View in: PubMed
    195. Czerniak B. [Ultrastructure of cells from fluids in human serous cavities. Study of the external covering (glycocalix) as well as of flattening and spreading of the cells]. Ann Acad Med Stetin. 1978; 24:565-83. PMID: 742756.
      View in: PubMed
    196. Krzystolik Z, Czerniak B. [Choroid leiomyoma (author's transl)]. Klin Oczna. 1977 Aug; 47(8):345-6. PMID: 904241.
      View in: PubMed
    197. Woyke S, Czerniak B. The morphology of cells in effusions settled on glass. Acta Cytol. 1977 Jul-Aug; 21(4):508-13. PMID: 269599.
      View in: PubMed
    198. Woyke S, Czerniak B. The surface coat of the human effusion cells. Acta Cytol. 1977 May-Jun; 21(3):447-54. PMID: 268128.
      View in: PubMed
    199. Woyke S, Czerniak B. The surface coat of human effusions cells. Acta Med Pol. 1977; 18(4):379-80. PMID: 76418.
      View in: PubMed
    200. Czerniak B, Mietkiewski J, Mazuryk R. [Effect of methotrexate on growth kinetics in Ehrlich's carcinoma]. Patol Pol. 1976 Jul-Sep; 27(3):219-30. PMID: 967534.
      View in: PubMed
    201. Domagala W, Czerniak B, Mietkiewski J, Szyroki L. [Ultrastructure of Kaposi's sarcoma]. Patol Pol. 1975 Oct-Dec; 26(4):517-24. PMID: 1215076.
      View in: PubMed
    202. Wiechowski S, Czerniak B, Marzymska G, Stankiewicz-Borkiel D. [Blastoma pulmonis]. Gruzlica. 1975 Aug; 43(8):743-9. PMID: 1158180.
      View in: PubMed
    203. Bayless TM, Paige DM, Ferry GD. Lactose intolerance and milk drinking habits. Gastroenterology. 1971 Apr; 60(4):605-8. PMID: 16944541.
      View in: PubMed
    204. Therapeutic Opportunities in the Intrinsic Subtypes of Muscle-Invasive Bladder Cancer. Hematology/Oncology Clinics of North America. 29:377-394.
    205. Blood group antigen expression in bladder tumors. Journal of Experimental and Clinical Cancer Research. 13:139-144.
    206. Uncommon Cancers of the Bladder. 18-26.
    207. Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer. Medicine (United States). 95.
    208. The use of thin-needle aspiration biopsy under control of computerized tomography in the diagnosis of orbital tumours. 185-188.
    209. Erratum. Nature Genetics. 41:1156.
    210. Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer. BJU International.
    211. Cytodiagnosis of early gastric carcinoma. Patologia Polska. 37:1-7.
    212. The molecular pathology of sarcomas. 475-491.
    213. Response to Bismar and Trpkov. Modern Pathology. 23:1041-1042.
    214. Uncommon Cancers of the Bladder. 23-33.
    215. Reply. Orthopedics. 34:837.
    216. Erratum to. World Journal of Urology. 30:723.
    217. Integrating murine and clinical trials with cabozantinib to understand roles of MET and VEGFR2 as targets for growth inhibition of prostate cancer. Clinical Cancer Research. 22:107-121.
    218. Erratum. Nature Genetics. 41:1156.
    219. Urachal carcinoma. Human Pathology. 46:1808-1814.
    220. Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer. European Urology.
    221. A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy. European Urology.
    222. Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis. Oncotarget. 7:20636-20654.
    223. Ultrastructure of cells from fluids of serous cavities in man. Roczniki Pomorskiej Akademii Medycznej W Szczecinie. Vol. 24:565-583.
    224. Molecular pathology and biomarkers of bladder cancer. 159-176.
    225. Mesenchymal chondrosarcoma. International Journal of Surgical Pathology. 8:291-301.
    226. Necrosis assessment in renal carcinoma-reply. Human Pathology. 43:151-152.
    227. RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation. Oncotarget. 7:69159-69172.
    228. Epithelial phenotype in Ewing's sarcoma/primitive neuroectodermal tumor. International Journal of Surgical Pathology. 8:59-65.
    229. Functional CAR Models for Large Spatially Correlated Functional Datasets. Journal of the American Statistical Association. 111:772-786.
    230. Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma. Modern Pathology. 28:1225-1235.
    231. RE. Polish Journal of Pathology. 61:183.
    232. Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use. EBioMedicine. 12:105-117.
    233. Origins of Bladder Cancer. Annual Review of Pathology. 11:149-174.
    234. Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer. Oncotarget. 7:80164-80174.
    CZERNIAK's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description